HCPCS Code Details - J7677

HCPCS Level II Code
Drugs administered other than oral method, chemotherapy drugs
HCPCS Code J7677
Description

Long description:
Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram

Short description:
Revefenacin inh non-com 1mcg

HCPCS Modifier1
HCPCS Pricing indicator 51 - Drugs
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code C - Carrier judgment
BETOS2 code D1G - Drugs Administered through DME
HCPCS Action code N - No maintenance for this code
Type of service 1 - Medical care
Effective date Effective Jul 01, 2019
Date added Added Jul 01, 2019
HCPCS Coding Procedures

HCPCS Modifiers

In HCPCS Level II, modifiers are composed of two alpha or alphanumeric characters.

Example: E0260-NU - Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress
NU” identifies the hospital bed as new equipment

ASP Drug pricing - J7677

Effective Code Dosage Payment
Limit
Vaccine AWP % Vaccine Limit Infusion AWP % DME infusion limit Blood AWP % Blood limit Clotting factor Note
April 1, 2024 - June 30, 2024 1 MCG 0.186 - - - - - -
January 1, 2024 - March 31, 2024 1 MCG 0.187 - - - - - -
October 1, 2023 - December 31, 2023 1 MCG 0.189 20% - - - - -
Jul 1, 2023 - Sep 30, 2023 1 MCG 0.196 20% - - - - -
April 1, 2023 - June 30, 2023 1 MCG 0.19 20% - - - - -

See also

  • HCPCS J7676 · Pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg

  • HCPCS J7680 · Terbutaline sulfate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram


1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”